Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
associated decrease » associated increase (Expand Search), associated disease (Expand Search), associated diseases (Expand Search)
decrease costs » increased costs (Expand Search), decreased across (Expand Search)
Showing 121 - 140 results of 28,836 for search '(( significant decrease costs ) OR ( significantly associated decrease ))', query time: 0.67s Refine Results
  1. 121
    Patient characteristics according to serum UA decrease rate grade.

    Patient characteristics according to serum UA decrease rate grade. by Kuniyuki Nakamura (13040299)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 122
    OS correlation of differentially expressed miRNAs (> 2-fold increase or decrease in HCC vs normal livers), according to KMP; miRNAs in bold are significantly correlated with OS.

    OS correlation of differentially expressed miRNAs (> 2-fold increase or decrease in HCC vs normal livers), according to KMP; miRNAs in bold are significantly correlated with OS. by Kayleigh Smith (17816667)

    Published 2024
    Save to List
    Saved in:
  3. 123
    Paclitaxel decreases average neurite outgrowth but not viability of iPSC-dSN.

    Paclitaxel decreases average neurite outgrowth but not viability of iPSC-dSN. by Geneva M. Cunningham (11909900)

    Published 2022
    Save to List
    Saved in:
  4. 124
    Diagram of the mechanism by which PFAS causes a decrease in constipation.

    Diagram of the mechanism by which PFAS causes a decrease in constipation. by Yifan Zhao (659636)

    Published 2024
    Save to List
    Saved in:
  5. 125
    Transformation from RPP to TSP for path merging.

    Transformation from RPP to TSP for path merging. by Almiqdad Elzein (13141038)

    Published 2022
    Save to List
    Saved in:
  6. 126
    iKIR score decreases protection associated with protective class II genotypes in T1D.

    iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

    Published 2024
    Save to List
    Saved in:
  7. 127
    Flow diagram of the study identification process.

    Flow diagram of the study identification process. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 128
    Overall characteristics of the included studies.

    Overall characteristics of the included studies. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 129
    Risk of bias assessment of included RCTs–Cochrane RoB tool 2.0.

    Risk of bias assessment of included RCTs–Cochrane RoB tool 2.0. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 130
    Funnel plot, using data from 3 trials of adverse events in MSCs therapy group and control group.

    Funnel plot, using data from 3 trials of adverse events in MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 131
    Summary of active RA clinical trials with MSC therapy that included a control group.

    Summary of active RA clinical trials with MSC therapy that included a control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 132
    Forest Plot of the incidence of adverse events in the MSCs therapy group and control group.

    Forest Plot of the incidence of adverse events in the MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 133
    Risk of bias assessment in the non-RCTs of Wang, 2013 –ROBINS-I tool.

    Risk of bias assessment in the non-RCTs of Wang, 2013 –ROBINS-I tool. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 134
    Forest Plot of the incidence of serious adverse events in MSCs therapy group and control group.

    Forest Plot of the incidence of serious adverse events in MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 135
    L’Abbé plot for the incidence of adverse events in the MSCs therapy group and control group.

    L’Abbé plot for the incidence of adverse events in the MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 136
    Forest Plot of the incidence of non-serious adverse events in MSCs therapy group and control group.

    Forest Plot of the incidence of non-serious adverse events in MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 137
    GRADE assessment.

    GRADE assessment. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 138
    DIP grouping and aggregation system.

    DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 139
    Linear trends of weekly prescription rates of NVBP varieties.

    Linear trends of weekly prescription rates of NVBP varieties. by Chenxuan Zhu (22622476)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 140
    DIP coding logic example.

    DIP coding logic example. by Chenxuan Zhu (22622476)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: